Pharma & Biotech

Upcoming Virtual Events

Join virtual conferences and connect with industry leaders worldwide. Discover upcoming events, access credible insights, and expand your professional network—all from home.

Symeres Strengthens US Foothold with Exemplify Buy

Dutch CDMO Symeres has acquired Exemplify Biopharma, a US-based contract research organization (CRO) based in Cranbury, New Jersey, USA. The deal further strengthens Symeres’ foothold in the US, where it already generates about 50% of its revenues.

Facing Strong Headwinds

So far, the pharmaceutical industry — including CMOs/CDMOs — has responded well to the outbreak of the Covid-19 pandemic.

Expansions in High-Potency API Manufacturing

DCAT Value Chain Insights rounds up recent expansion activity for highly potent drug substances and drug products.

Understanding the Requirements of Safe HPAPI Manufacturing

The pharmaceutical industry is increasingly focused on the development of specialized drug products with new treatment modalities, including previously undruggable targets for oncology and other areas.

The Rise of HPAPI Molecules

For biopharma leaders it is more critical than ever to secure the capabilities to contain, handle, develop and manufacture highly potent APIs.

Injecting Growth and Innovation

Why CDMOs Should Consider Value-Based Pricing

The Importance of On-line Process Control

Live-Broadcasting of Bioprocesses

Continuous Processing

Biotechnological Production of Rare Functional Sugar

Biomade Peptides

Coupling Trends in Cultured Meat and Entomophagy

Sustainable Chemical Supply Chains

The Pharma CDMO Challenge

CDMO Market Forces Re-shape of M&A Activity

Evolution of Technology

Managing Highly Challenging GMP Processes

Winning Strategies in the Pharmaceutical CDMO Industry

Diagnosis: Innovation Insufficiency – Treatment: Combination Therapy